JFNAX

Janus Henderson Global Life Sciences Fund Class A [JFNAX] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

JFNAX Stock Summary

Top 10 Correlated ETFs

JFNAX

Top 10 Correlated Stocks

JFNAX

In the News

JFNAX Financial details

Company Rating
-
Market Cap
5.28B
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
0.02
Dividend %
0.02%
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
3.17%
SMA50
-2.99%
SMA100
-2.99%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
60.56-73.81
52W High
-10.3%
52W Low
+9.13%
RSI
63
Rel Volume
-
Avg Volume
-
Volume
Perf Week
2.55%
Perf Month
0.24%
Perf Quarter
-1.73%
Perf Half Y
-6.35%
-
-
-
-
Beta
0.73
-
-
Volatility
0.52%, 1.34%
Prev Close
0%
Price
65.48
Change
0%

JFNAX Financial Performance

JFNAX Dividend History

JFNAX Frequently Asked Questions

What is Janus Henderson Global Life Sciences Fund Class A stock symbol ?

Janus Henderson Global Life Sciences Fund Class A is a US stock and trading under the symbol JFNAX

What is Janus Henderson Global Life Sciences Fund Class A stock quote today ?

Janus Henderson Global Life Sciences Fund Class A stock price is $65.48 today.

Is Janus Henderson Global Life Sciences Fund Class A stock public?

Yes, Janus Henderson Global Life Sciences Fund Class A is a publicly traded company.

Something similar

Top by Market Cap
EMBASSY.NS
GOOG
V
0YXG.L
CMC.DE
Top Correlated ETFs
IXJ
VHT
FHLC
PTH
IYH
Top Correlated Stocks
SHSCX
SHSKX
SHSSX
SHISX
BHSRX
Similar Market Cap
7527.T
MINDTECK.NS
SPTS
000521.SZ
GKOS

Company Profile

Financial Services Asset Management - Global
  • Market Capitalization 5.28B
  • Headquarters US
  • IPO Date 2009-07-06

The investment seeks long-term growth of capital. The fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that the portfolio managers believe have a life science orientation. In the fund's pursuit of companies with a life science orientation, the fund has a fundamental policy to normally invest at least 25% of its total assets in securities of companies that are categorized in the "life sciences" sector.